Zacks Investment Research upgraded shares of LIFEPOINT HOSP (LPNT) from UNDERPERFORM to NEUTRAL on January 08, 2013, with a target price of $41.60.
LifePoint Hospitals, Inc. is engaged in the operation of general, acute care hospitals in non-urban communities. The company's general, acute care hospitals usually provide the range of medical and surgical services commonly available in hospitals in non-urban markets. These hospitals also provide diagnostic and emergency services, as well as outpatient and ancillary services including outpatient surgery, laboratory, radiology, respiratory therapy and physical therapy.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on LIFEPOINT HOSP (LPNT),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment